Roivant Sciences Ltd (ROIV)
Gross profit margin
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | -597,426 | -556,728 | -546,797 | -563,761 | -567,648 | -591,710 | -524,745 | -796,621 | -726,788 |
| Revenue (ttm) | US$ in thousands | 90,017 | 87,063 | 67,973 | 44,317 | 33,312 | 22,259 | 36,493 | 44,730 | 48,245 |
| Gross profit margin | -663.68% | -639.45% | -804.43% | -1,272.11% | -1,704.03% | -2,658.30% | -1,437.93% | -1,780.95% | -1,506.45% |
March 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-597,426K ÷ $90,017K
= -663.68%
The gross profit margin of Roivant Sciences Ltd has been consistently negative across the periods provided in the table, indicating that the company's cost of goods sold exceeds its revenue from sales. The magnitude of the negative gross profit margin has fluctuated over time, ranging from -663.68% to -2,658.30%. This suggests that the company may be experiencing challenges in effectively managing its production costs relative to its sales revenue. Further analysis of the company's cost structure and pricing strategies is recommended to pinpoint the underlying issues contributing to the persistently negative gross profit margin.
Peer comparison
Mar 31, 2024